Clincosm LogoSign in Get a demo

car

Showing 1 - 13 of 13
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

CAR, B Cell Lymphoma, Relapsed Non-Hodgkin Lymphoma Trial in Suzhou (ThisCART19A with Dose Level 1, ThisCART19A with Dose Level

Recruiting
  • CAR
  • +2 more
  • ThisCART19A with Dose Level 1
  • ThisCART19A with Dose Level 2
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Jan 18, 2023

CAR, Refractory Acute Lymphoblastic Leukemia, Relapsed Adult ALL Trial in Suzhou (Treatment)

Recruiting
  • CAR
  • +2 more
  • Suzhou, Jiangsu, China
    The First Affiliated Hospital of Soochow University
Dec 27, 2022

Lymphoblastic Leukemia, Lymphoblastic Leukemia in Children, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (Anti-CD19

Recruiting
  • Lymphoblastic Leukemia
  • +5 more
  • Anti-CD19 CAR T-cells
  • Singapore, Singapore
  • +1 more
Dec 4, 2022

Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia in Children Trial in Singapore (Phase

Recruiting
  • Lymphoblastic Leukemia
  • +4 more
  • Phase I
  • Phase II
  • Singapore, Singapore
    KK Women's and Children's hospital
Jun 20, 2022

CAR, Acute Myeloid Leukemia Trial in Hefei (TAA05 cell injection)

Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • TAA05 cell injection
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Nov 3, 2021

Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (CAR

Recruiting
  • Lymphoblastic Leukemia, Acute, Childhood
  • +6 more
  • CAR T-cell therapy
  • Singapore, Singapore
    Allen Yeoh Eng Juh
Sep 7, 2021

Lymphoblastic Leukemia, Acute, Childhood, Lymphoblastic Leukemia, Lymphoblastic Leukemia, Acute Adult Trial in Singapore (CAR

Recruiting
  • Lymphoblastic Leukemia, Acute, Childhood
  • +5 more
  • CAR T-cell therapy
  • Singapore, Singapore
    Allen Yeoh Eng Juh
Sep 7, 2021

CAR Trial in Hefei (CD19/CD20 CAR-T cell infusion)

Recruiting
  • CAR
  • CD19/CD20 CAR-T cell infusion
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Mar 4, 2021

CAR, Acute Myeloid Leukemia Trial in Hefei (Chimeric antigen receptor T cells (car-t))

Recruiting
  • CAR
  • Acute Myeloid Leukemia
  • Chimeric antigen receptor T cells (car-t)
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Mar 4, 2021

CAR, Malignant Tumors Trial in Hefei (Chimeric antigen receptor modified ?d T cells)

Recruiting
  • CAR
  • Malignant Tumors
  • Chimeric antigen receptor modified γδ T cells
  • Hefei, Anhui, China
    Anhui Provincial Hospital
Mar 4, 2021

CAR, Solid Tumor Trial in Hefei (Targeting CD276 autologous chimeric antigen receptor T cells)

Recruiting
  • CAR
  • Solid Tumor
  • Targeting CD276 autologous chimeric antigen receptor T cells
  • Hefei, Anhui, China
    Bin Hu Hospital
Dec 28, 2020

Hepatocellular Carcinoma, Immunotherapy, CAR Trial in Guangzhou (GPC3 and/or TGFß targeting CAR-T cells)

Recruiting
  • Hepatocellular Carcinoma
  • +5 more
  • GPC3 and/or TGFβ targeting CAR-T cells
  • Guangzhou, Guangdong, China
  • +1 more
Nov 28, 2020

Pancreatic Cancer, CAR Trial in Harbin (Chimeric antigen receptor T cell)

Unknown status
  • Pancreatic Cancer
  • CAR
  • Chimeric antigen receptor T cell
  • Harbin, Heilongjiang, China
    Harbin Medical University
Aug 27, 2017